Kihara James — SEC Form 4 filings
SEC reporting owner CIK 1816160. 17 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-02-27 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 15 filings — 40,798 shares, $890,215 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 11,421 shares @ $26.08 ($297,912) in ACADIA PHARMACEUTICALS INC, filed 2026-06-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | 17 | — | 19 legs · 40,798 sh · $890,215 | 38 |
Form 4 filings — Kihara James
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Sale (S): 11,421 @ $26.08 | EDGAR |
| 2026-05-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Sale (S): 5,401 @ $21.18 | EDGAR |
| 2026-05-05 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,596 · Sale (S): 1,332 @ $21.79 · Option exercise (M): 2,596 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,010 · Sale (S): 1,030 @ $22.20 · Option exercise (M): 2,010 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,627 · Sale (S): 833 @ $21.47 · Option exercise (M): 2,142 · Sale (S): 1,097 @ $21.65 · Sale (S): 12 @ $21.73 · Option exercise (M): 1,627 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-10 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 21,766 (derivative) @ $0 · Grant/award (A): 6,332 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 3,966 · Option exercise (M): 3,966 · Sale (S): 4,084 @ $23.69 · Option exercise (M): 3,966 (derivative) @ $0 · Option exercise (M): 3,966 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Sale (S): 2,000 @ $25 · Sale (S): 2,000 @ $20 | EDGAR |
| 2025-05-02 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,596 · Sale (S): 1,327 @ $14.60 · Option exercise (M): 2,596 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,010 · Sale (S): 1,028 @ $14.82 · Option exercise (M): 2,010 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,142 · Sale (S): 1,095 @ $17.05 · Grant/award (A): 22,152 (derivative) @ $0 · Grant/award (A): 6,510 (derivative) @ $0 · Option exercise (M): 2,142 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 840 · Sale (S): 475 @ $19.96 · Option exercise (M): 840 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 3,965 · Option exercise (M): 3,965 · Sale (S): 4,073 @ $16.81 · Option exercise (M): 3,965 (derivative) @ $0 · Option exercise (M): 3,965 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,596 · Sale (S): 1,326 @ $16.94 · Option exercise (M): 2,596 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 2,010 · Option exercise (M): 1,489 · Sale (S): 1,028 @ $17.87 · Sale (S): 762 @ $17.87 · Option exercise (M): 2,010 (derivative) @ $0 · Option exercise (M): 1,489 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 13,964 (derivative) @ $0 · Grant/award (A): 8,568 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 840 · Sale (S): 474 @ $24.67 · Option exercise (M): 840 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816160 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →